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Abstract
We evaluated the extent to which genetic and environmental factors influenced anorexia nervosa 
(AN), major depressive disorder (MDD), and suicide attempts (SA). Participants were 6,899 
women from the Swedish Twin study of Adults Genes and Environment. A Cholesky 
decomposition assessed independent and overlapping genetic and environmental contributions to 
AN, MDD, and SA. Genetic factors accounted for a substantial amount of liability to all three 
traits; unique environmental factors accounted for most of the remaining liability. Shared genetic 
factors may underlie the co-expression of these traits. Results underscore the importance of 
assessing for signs of suicide among individuals with AN.
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INTRODUCTION
Suicide is a global problem. In 2012, suicide was the second leading cause of death among 
15–29 year olds (World Health Organization, 2015) and the leading cause of death among 
15–19 year old females (Patton et al., 2009). The World Health Organization estimates that 
800,000 people worldwide end their lives by suicide each year. Around 90% of individuals 
who commit suicide are believed to suffer from psychiatric disorders (Hawton & van 
Heeringen, 2009), with anorexia nervosa (AN) and major depressive disorder (MDD) among 
the disorders with the highest risk (Chesney, Goodwin, & Fazel, 2014). In this paper, we 
explore the connections among AN, MDD, and suicide attempts (SA) with the aim of 
clarifying the role that genetic and environmental factors play on these phenotypes.
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Mortality in AN is amongst the highest of all psychiatric disorders (Hoang, Goldacre, & 
James, 2014), with suicide being one of the leading causes of death and implicated in about 
20% of deaths (Arcelus et al., 2011). According to a recent meta-analysis, individuals with 
AN have an 18.1 [95% confidence interval (CI): 11.5, 28.7] times higher risk of dying from 
suicide than the general population of females aged 15–34 years (Keshaviah et al., 2014). 
Although the suicide rate in those with AN may be declining in recent decades (Preti et al., 
2011), it remains substantially elevated compared with the general population (Pisetsky et 
al., 2013). Additionally, the lifetime prevalence of SA in patients ranges from 3.0%–29.7% 
(Bulik et al., 2008; Forcano et al., 2011; Franko & Keel, 2006; Runfola et al., 2014). 
According to the Interpersonal Theory of Suicide, an individual has to have both an 
increased fearlessness about death and an increased tolerance to pain in order to be capable 
of attempting suicide (Ribeiro et al., 2014). The repeated exposure to pain via restriction 
(Selby et al., 2010) coupled with decreased pain sensitivity (whether acquired or inborn) 
(Papezová, Yamamotová, & Uher, 2005), may contribute to the increased prevalence of SA 
in this population.
The association between MDD and suicide is well known. Psychological autopsy studies 
have found that 30%–90% of individuals who die from suicide suffered from MDD 
(Isometsa, 2001). MDD is common in individuals with AN: 50–75% of individuals with AN 
experience lifetime MDD (Calugi et al., 2014; Fernandez-Aranda et al., 2007; Mischoulon et 
al., 2011; Rastam, Gillberg, & Gillberg, 1995; Wade et al., 2000), which may be a risk factor 
for suicide in AN (Preti et al., 2011). Individuals with an eating disorder who attempt suicide 
are more likely to have a lifetime history of MDD than individuals with an eating disorder 
who do not attempt suicide (Anderson et al., 2002; Bulik et al., 2008; Corcos et al., 2002; 
Favaro & Santonastaso, 1997). In fact, over 80% of individuals with AN who attempted 
suicide reported that their worst attempt occurred during an episode of MDD (Bulik et al., 
2008).
Behavioral genetic methods can explicate the nature of the relationship among AN, MDD, 
and suicide. Genetic factors contribute to the liability to AN, MDD, and suicide (Bulik et al., 
2010; Hawton, Saunder, & O'Connor, 2012; Kendler et al., 2006) and, by using a genetically 
informative twin sample, we can evaluate the extent to which these phenotypes share genetic 
or environmental factors. A recent study by Wade et al. (Wade et al., 2015) gave a glimpse 
into the relation among broadly defined eating disorders (including AN, bulimia nervosa, 
binge eating disorder, and purging disorder), MDD, and broadly defined suicidality (ranging 
from transitory thoughts to suicide attempts). Their model revealed a common genetic 
influence on eating disorders and suicidality (but not MDD), and no appreciable influence of 
common environmental factors.
Here, we refine and extend the results of Wade et al. (Wade et al., 2015) by focusing on AN, 
which has the highest rates of suicidality (Franko & Keel, 2006), rather than incorporating 
multiple eating disorders simultaneously, and only including health care detected suicide 
attempts and death by suicide. We applied multivariate twin models to data from women to 
determine whether shared genetic and environmental factors contributed to liability to AN, 
MDD, and SA.
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METHOD
Participants
Participants were women from monozygotic (MZ) and same-sex dizygotic (DZ) twin pairs 
who participated in the Swedish Twin study of Adults Genes and Environment (STAGE). 
STAGE, a population-based prospective study of Swedish twins born 1959–1985, assessed 
more than 30 different health and demographic topics (Furberg et al., 2008; Lichtenstein et 
al., 2006). Data were collected on-line in 2005; twins were between 20 and 47 years old. 
The Regional Ethics Committee of Karolinska Institutet and the University of North 
Carolina’s Biomedical Institutional Review Board approved this study.
Zygosity
Zygosity was assigned based on responses from two questions: (Q1) During childhood, were 
you and your twin partner as alike as ‘two peas in a pod’ or no more alike than siblings in 
general? and (Q2) How often did strangers have difficulty distinguishing between you and 
your twin partner when you were children? Twins were classified as MZ if both twins within 
a pair responded ‘alike as two peas in a pod’ for Q1 and ‘almost always’ or ‘often’ for Q2. 
Twins were classified as DZ if both twins responded ‘not alike’ for Q1 and ‘seldom,’ 
‘almost never’, or ‘never’ for Q2. All other twins were classified as ‘not determined.’ This 
algorithm was validated using 47 single nucleotide polymorphisms in 198 randomly selected 
twin pairs (Lichtenstein et al., 2002). Ninety-five percent were correctly classified; ten pairs 
(8 MZ and 2 DZ) were misclassified.
Measures
Anorexia Nervosa—A lifetime history of AN was assessed in STAGE using an expanded, 
on-line Structured Clinical Interview for DSM-IV (SCID)-based instrument (First et al., 
1997). AN was considered present if the following criteria were met: 1) having a period of 
time when the respondent weighed much less than people thought she should weigh and had 
a BMI < 18.55; 2) being slightly, somewhat, very, or extremely afraid of gaining weight or 
becoming fat; and 3) feeling slightly, somewhat, very, or extremely fat when at low weight. 
Amenorrhea, Criterion D, was not required (Dellava et al., 2011) and is consistent with 
DSM-5.
Depression—In STAGE, lifetime history of DSM-IV-TR (American Psychiatric 
Association, 2000) MDD was considered present if, during the same two week period, 1) the 
participant indicated the presence of at least five of the following: depressed mood, loss of 
interest or pleasure, significant weight change or appetite change, insomnia or hypersomnia, 
psychomotor agitation or retardation, fatigue, feeling worthless or full of guilt, problems 
concentrating, and suicidal ideation, with either depressed mood or loss of interest in nearly 
all activities most of the day endorsed; and 2) the participant indicated that the symptoms 
caused significant impairment or distress.
Suicide Attempts—Information regarding SA was obtained from the National Patient 
Register [years 1973–2009; (National Board of Health and Welfare, 2012)]. Information 
regarding death by suicide was obtained from the Cause of Death Register [years 2005–2008 
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for this study; (National Board of Health and Welfare, 2010)]. The National Patient Register, 
established in 1964, records all hospital admissions in Sweden. As of 1987 and 2001, all 
inpatient and outpatient admissions, respectively, are reported and maintained in the 
database. For each admission, the primary discharge diagnosis and as many as eight 
secondary diagnoses are listed using codes from the International Classification of Diseases, 
Eighth Revision [ICD-8; 1973–1986 (World Health Organization, 1967)], International 
Classification of Diseases, Ninth Revision [ICD-9; 1987–1996 (World Health Organization, 
1978)] or International Classification of Diseases, Tenth Revision [ICD-10; 1997-present 
(World Health Organization, 1992)]. Similarly, primary and secondary causes of death, as 
reported on death certificates, are listed in the Cause of Death Register. Since 1961, >99% of 
all deaths both in Sweden and abroad are reported. In both registers, definite SA and causes 
of death by suicide are coded using ICD codes: ICD-8 (World Health Organization, 1967) 
and ICD-9 (World Health Organization, 1978): E950–E958; ICD-10 (World Health 
Organization, 1992): X60–X64. Since ≤4 women died by suicide after participation in 
STAGE in 2005 (Pisetsky et al., 2013), one suicide variable was created. Any person 
identified as having attempted and or died by suicide was classified as having a SA.
Information from STAGE, the National Patient Register, and the Cause of Death Register 
was merged using a personal identification number that is assigned to all individuals born in 
Sweden or residing in Sweden for at least one year (Ludvigsson et al., 2009).
Statistical Analyses
Biometrical twin modeling was used to assess the relative contributions of genetic and 
environmental factors that influence liability to AN, MDD, and SA, and to estimate whether 
genetic and environmental factors are shared across traits. Additive genetic effects (A) are 
those genetic factors which influence a trait. Common environmental effects (C) are 
environmental influences which both members of a twin pair experience that increase 
similarity between twins. Unique environmental factors (E) make twins less similar; this 
term also includes measurement error. By comparing the intrapair correlation for MZ twins 
to the intrapair correlation for DZ twins, classic twin modeling assesses the contribution of: 
(1) additive genetic effects (i.e., heritability, a2); (2) common environmental effects (c2); and 
(3) unique environmental effects (e2) to the liability of a phenotype. The sum these effects, 
a2 + c2 + e2, accounts for 100% of the underlying variance of the phenotype.
A Cholesky decomposition was applied with Mx (M. C. Neale et al., 1999) using raw 
ordinal data that allowed for missing data within a twin and when no cotwin information 
was available. This approach decomposes the variance of the individual phenotypes, i.e., 
AN, MDD, and SA, and the covariance among these phenotypes to estimate: 1) the 
contribution of additive genetic, common environmental, and unique environmental factors; 
and 2) the genetic, common environmental, and unique environmental correlations (ra, rc, 
and re, respectively). These correlations indicate the extent to which the traits share the 
respective factors. When no cotwin data are available, the twin’s information is still useful 
because it contributes to the variance, but not correlations, of the phenotypes.
The full model (Model I), in which all parameter estimates (a2, c2, and e2) for AN, MDD, 
and SA, as well as the parameter correlations (ra, rc, and re) for each pair of disorders, was 
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applied to the data. We then applied five nested models: Model II, all common 
environmental correlations were set to zero; Model III, all common environmental variance 
parameters and all common environmental correlations were set to zero; Model IV, the 
common environmental variance parameters and correlations were set to zero and the 
genetic correlations were set to zero; Model V, the common environmental variance 
parameters and correlations and the unique environmental correlations were set to zero; and 
Model VI, the common environmental variance parameters and correlations were set to zero 
and the genetic variance parameters and correlations were set to zero. The fit of each nested 
model was compared with the full model. If the difference in χ2 values between the nested 
model and the full model (Neale & Cardon, 1992), where degrees of freedom (df) is equal to 
the difference between the df of the nested model and the full model, was not significant, 
indicating no decrement in fit, the nested model was retained because it was the more 
parsimonious model. The model with the lowest Akaike’s Information Criteria [AIC; 
(Akaike, 1987)], the best-fitting model with regard to precision and complexity, was then 
selected as the overall best-fitting model. Results from the full and best-fitting models are 
presented.
RESULTS
Sample Characteristics
Our final sample for modeling included 6,899 women from MZ and same-sex DZ twin pairs. 
There were 1,651 MZ and 1,109 DZ pairs with complete data, 256 MZ and 245 DZ pairs 
with incomplete data, and 222 MZ and 155 DZ individuals with no cotwin information. The 
mean (sd) age of the sample was 33.0 (7.6) years.
The prevalence of each disorder was: AN = 3.6% (n = 245), MDD = 26.2% (n = 1,659), and 
SA (including suicide completions) = 1.9% (n = 128). A total of 226 women (3.3%) met 
criteria for both AN and MDD, 17 (0.2%) had AN and SA, and 90 (1.3%) had MDD and 
SA. Fifteen women had a lifetime history of all three phenotypes. No differences in 
prevalence between MZ and DZ twins were observed for AN (χ2 = 1.31, p < .26), MDD (χ2 
= 0.11, p < .74), or SA (χ2 = 0.32, p < .58). The phenotypic correlations were .34 (95% CI: .
27, .41), .30 (95% CI: .18, .42), and .50 (95% CI: .42, .57) for AN-MDD, AN-SA, and 
MDD-SA, respectively.
Twin Models
Table 1 lists the results from fitting the full model (Model I) and the five nested models. 
Based on the χ2 difference tests, Models IV and VI fit significantly worse than the full 
model. Model III was considered to be the best-fitting model because it had the lowest AIC 
value.
Table 2 presents the results for the full (Model I) and best-fitting (Model III) models. Results 
from the full model show that genetic factors account for 38% (95% CI: 8%, 53%) of the 
liability to AN, 44% (95% CI: 24%, 50%) of the liability to MDD, and 58% (95% CI: 8%, 
78%) of the liability to SA. Unique environmental factors account for most of the remaining 
liability. The genetic correlations suggest some sharing of genetic risk factors: ra=.49 for AN 
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with MDD, ra=.52 for AN with SA, and ra=.77 for MDD with SA. All correlations in the full 
model have wide confidence intervals, indicating a lack of power to obtain precise estimates. 
Genetic and unique environmental parameter estimates for the best-fitting model were 
similar to those obtained from the full model.
DISCUSSION
This study sheds light on factors that underlie the commonly observed phenomenon of 
comorbid AN, MDD, and SA and points to mechanisms that implicate shared genetic factors 
in their co-occurrence. In contrast, the 95% CIs for unique environmental correlations for 
AN and SA, as well as MDD and SA, included zero, suggesting that unique environmental 
effects contributing to each of these phenotypes might not overlap but, rather, be trait 
specific.
The lifetime prevalence of AN in our sample was somewhat higher than the prevalence 
reported among female Australian (Wade et al., 2006) and Finnish (Keski-Rahkonen et al., 
2007) twins (3.6% versus 1.9% and 2.2%, respectively), but well in line with estimates that 
AN affects between 1%–4% of the population (Hudson et al., 2007; Smink, van Hoeken, & 
Hoek, 2012). This increased prevalence could be due to the use of a broader AN definition in 
our study. The prevalence of SA was lower than that reported in a large nationally 
representative US sample [4.6%; (Kessler, Borges, & Walters, 1999)]; however, it should be 
noted that SA in the present study only reflected attempts resulting in clinical care and thus 
less serious attempts that did not warrant medical attention would not have been detected, 
yielding a conservative estimate of SA. Although the lifetime prevalence of MDD in our 
sample was higher (26.6%) than in the US sample [16.6%; (Kessler et al., 2005)], which 
could reflect true differences or variable estimates due to different assessment strategies (i.e., 
self-report versus interview), it was similar (25.1% in women) to that reported in another 
Swedish twin sample (Kendler et al., 2006).
Previous studies have consistently documented that both AN and MDD are associated with a 
higher risk of SA [e.g., (Bolton et al., 2008; Bulik et al., 2008; Chesney et al., 2014; Forcano 
et al., 2011; Pisetsky et al., 2013)]. Furthermore, genetic factors are known to play a role in 
all three phenotypes [e.g., (Bulik et al., 2010; Hawton et al., 2012; Roy, Segal, & 
Sarchiapone, 1995)]. However, the heritability estimate for AN in this study was lower than 
that observed in prior reports; this is likely due to the broader AN definition used here 
(Dellava et al., 2011). Our observations that the comorbidity of AN and SA and of MDD and 
SA can be largely attributed to shared genetic factors are similar to those reported by Wade 
et al. (Wade et al., 2015) in a general population sample of twins. The authors found that 
eating disorders are associated with increased risk for suicidality and the comorbid pattern 
appeared to be almost entirely explained by shared genetic factors.
Although results from our multivariate twin modeling show that genetic factors account for a 
large part of the liability of the three traits, unique environmental factors (including 
measurement error) account for essentially all the remaining liability. Common 
environmental factors play a negligible role in liability to any of the three traits.
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The main finding in the current study is an indication of shared biological underpinnings 
across AN, MDD, and SA. Genetic epidemiological studies reveal the proportion of genetic 
variance in liability to a trait attributable to additive genetic factors, and trivariate designs 
such as that employed here allow us to estimate the extent to which genetic and 
environmental factors are shared among phenotypes. Importantly, they do not directly 
measure genetic or environmental risk factors. Thus, to further our knowledge, genetic 
epidemiological studies have to be enriched with measured genotypes and environmental 
exposures. The calculation of genetic and environmental risk scores will allow us to estimate 
risk on an individual level and promote understanding of the structure, function, and 
processes of genetic and environmental risk factors. Ultimately, this will pave the way for 
the development of more precise diagnostics that in turn will improve both prevention and 
treatment.
Limitations
The results of this study should be evaluated within the context of the limitations. First, the 
data used came from adult women from Sweden; results might not be generalizable to men 
or to different ancestry and age groups. Second, STAGE data were collected via computer-
administered assessments. Although computer-administered self-report assessments might 
be less precise than interview-based assessment methods, participants might be more 
forthcoming with sensitive information (Lind et al., 2013). Third, SA were only captured if 
the result of the attempt required clinical care. Thus, results may only apply to more serious 
attempts. Fourth, causal conclusions regarding which specific genetic and/or unique 
environmental factors that may be involved in the associations between the three disorders 
cannot be determined. Fifth, there is likely some confounding between MDD and both AN 
and SA since the symptom list for MDD includes appetite, weight changes, and suicidal 
ideation.
Conclusions and Clinical Implications
Our results help us understand processes that underlie the common clinical observation of 
MDD and suicide in individuals with AN. They show that the comorbidity of AN and SA 
that require clinical care is largely due to genetic factors. This is in contrast to AN and 
MDD, where the unique environmental correlation is substantial. Second, our results are 
meaningful for clinical practice. Although caution must be engaged when transferring 
knowledge from the population to individuals, our results encourage clinicians to consider 
that shared biology could underlie the frequency with which suicide attempts occur in 
individuals with AN. As such, clinicians should screen for a family history of SA in 
individuals with AN, regardless of lifetime MDD status. These findings further underscore 
the seriousness of AN and alert clinicians to be vigilant for signs of suicide. Third, 
quantifying the contribution of genetic and environmental factors to AN, MDD, and SA 
lends evidence to explanatory models that account for their co-occurrence. Our models 
provide valuable insight into the association among these traits and to factors that contribute 
to the lethality of AN.
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